Consider your patients’ ocular comfort needs when
prescribing an ophthalmic NSAID after cataract surgery
*IQVIA NPA Monthly. November 2018
Formulated to be close to the physiological pH of natural tears, with a pH of 7.81
PROLENSA® delivers consistent potency, every drop, every time, with no shaking required1
PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Clickhere for full Prescribing Information for PROLENSA®.